Compassionate Use / Early Access Programme – France
Early access request dossier / nominative or cohort access documentationStatutory
Description & Eligibility
France provides early access mechanisms for medicines intended to treat serious, rare, or debilitating diseases when there is no suitable therapeutic alternative and the product is presumed to be innovative or has strong data support. The scheme is managed through the national early-access framework overseen by ANSM and the health authorities.
Eligibility Criteria
Patients with serious, rare, or debilitating diseases lacking suitable treatment alternatives, typically when the medicine is not yet authorized or not yet reimbursed.
Legal Reference / Source
Code de la santé publique, early-access provisions (accès précoce / accès compassionnel)
Compassionate Use / Early Access Programme – France
| Approval Form | Early access request dossier / nominative or cohort access documentation |
| Legal Status | Statutory |
| Source Ref. | Code de la santé publique, early-access provisions (accès précoce / accès compassionnel) |
| Countries | 0 countries |
Compliance Check
Legal Review7/24/2026
Global ValidityVerified